Literature DB >> 11533201

The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck.

Z Hanna1, X Weng, D G Kay, J Poudrier, C Lowell, P Jolicoeur.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Nef protein is an important determinant of AIDS pathogenesis. We have previously reported that HIV-1 Nef is responsible for the induction of a severe AIDS-like disease in CD4C/HIV transgenic (Tg) mice. To understand the molecular mechanisms of this Nef-induced disease, we generated Tg mice expressing a mutated Nef protein in which the SH3 ligand-binding domain (P(72)XXP(75)XXP(78)) was mutated to A(72)XXA(75)XXQ(78). This mutation completely abolished the pathogenic potential of Nef, although a partial downregulation of the CD4 cell surface expression was still observed in these Tg mice. We also studied whether Hck, one of the effectors previously found to bind to this PXXP motif of Nef, was involved in disease development. Breeding of Tg mice expressing wild-type Nef on an hck(-/-) (knockout) background did not abolish any of the pathological phenotypes. However, the latency of disease development was prolonged. These data indicate that an intact PXXP domain is essential for inducing an AIDS-like disease in CD4C/HIV Tg mice and suggest that interaction of a cellular effector(s) with this domain is required for the induction of this multiorgan disease. Our findings indicate that Hck is an important, but not an essential, effector of Nef and suggest that another factor(s), yet to be identified, may be more critical for disease development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533201      PMCID: PMC114506          DOI: 10.1128/JVI.75.19.9378-9392.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  The HIV Nef protein alters Ca(2+) signaling in myelomonocytic cells through SH3-mediated protein-protein interactions.

Authors:  M Foti; L Cartier; V Piguet; D P Lew; J L Carpentier; D Trono; K H Krause
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

2.  Analysis of the SH3-binding region of HIV-1 nef: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket.

Authors:  H M Craig; M W Pandori; N L Riggs; D D Richman; J C Guatelli
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

Review 3.  Interactions of HIV-1 NEF with cellular signal transducing proteins.

Authors:  G H Renkema; K Saksela
Journal:  Front Biosci       Date:  2000-02-01

4.  Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.

Authors:  E T Sawai; M S Hamza; M Ye; K E Shaw; P A Luciw
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes.

Authors:  H Cheng; J P Hoxie; W P Parks
Journal:  Virology       Date:  1999-11-10       Impact factor: 3.616

Review 6.  The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors.

Authors:  V Piguet; O Schwartz; S Le Gall; D Trono
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

7.  HIV-2 and SIV nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution.

Authors:  Y Collette; S Arold; C Picard; K Janvier; S Benichou; R Benarous; D Olive; C Dumas
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

8.  Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection.

Authors:  L Alexander; E Weiskopf; T C Greenough; N C Gaddis; M R Auerbach; M H Malim; S J O'Brien; B D Walker; J L Sullivan; R C Desrosiers
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease.

Authors:  Z Hanna; D G Kay; M Cool; S Jothy; N Rebai; P Jolicoeur
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn.

Authors:  C J Fitzer-Attas; M Lowry; M T Crowley; A J Finn; F Meng; A L DeFranco; C A Lowell
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

View more
  43 in total

Review 1.  HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Authors:  Alison L Greenway; Gavan Holloway; Dale A McPhee; Phoebe Ellis; Alyssa Cornall; Michael Lidman
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

2.  Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.

Authors:  Stéphane Betzi; Audrey Restouin; Sandrine Opi; Stefan T Arold; Isabelle Parrot; Françoise Guerlesquin; Xavier Morelli; Yves Collette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

Review 3.  Viral subversion mechanisms in chronic kidney disease pathogenesis.

Authors:  Leslie A Bruggeman
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

Review 4.  Src family kinases in chronic kidney disease.

Authors:  Jun Wang; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-14

5.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 6.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

7.  Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor.

Authors:  Ronald P Trible; Lori Emert-Sedlak; Thomas E Wales; Velpandi Ayyavoo; John R Engen; Thomas E Smithgall
Journal:  J Mol Biol       Date:  2007-09-11       Impact factor: 5.469

Review 8.  Small molecule inhibitors of the HIV-1 virulence factor, Nef.

Authors:  Thomas E Smithgall; Gary Thomas
Journal:  Drug Discov Today Technol       Date:  2013-12

Review 9.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro.

Authors:  Fatiha Radja; Denis G Kay; Steffen Albrecht; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.